Visual summary (bibliometrics / name‑disambiguation)

Key scientific points (visualize first, read second)

1. Name disambiguation is the dominant uncertainty: your provided author record (h=3, 28 cites, 5 papers) is a small corpus focused on tissue‑engineering / vascular scaffolds, while OpenAlex returns multiple distinct matches for the string "Yong‑Zhen Zhang" including at least one high‑impact profile (h=27, works=86, cited_by=4086). Without persistent identifiers (ORCID) or institutional affiliations, bibliometric assignment can be misleading.
2. Scientific footprint (from your provided papers): the five listed papers are focused on tissue-engineered venous valves, endothelial progenitor cells, decellularized scaffolds and applied anatomy, which is a coherent clinical/biomaterials niche but limited in sample size and citations (per your input).
3. Consequences: low local citation counts + small paper count suggest the provided profile (if correct and distinct) is early‑career or specialist with limited external impact; but the existence of high‑impact homonyms means we cannot accept the small metrics at face value for general claims about "Yong‑Zhen Zhang" without disambiguation.

Primary recommendation: resolve author identity using institutional affiliation, ORCID, or DOIs of the specific papers before using bibliometrics to judge scientific strength; otherwise any evaluation conflates multiple researchers sharing the same romanized name.

Raw evidence & citations

OpenAlex author entry that matches a 'Yong‑Zhen Zhang' with substantial impact (works_count=86, cited_by_count=4086, h_index=27), demonstrating the name ambiguity risk (OpenAlex aggregated author record):

OpenAlex author record (A5069516785)

Your supplied author-paper list (5 papers on tissue-engineered venous valves etc.) indicates a focused experimental niche but limited public citation impact (total citations=28 per your input). Those experimental papers (titles supplied) appear to be surgical/biomaterials animal-model work — typical of translational, applied preclinical research but not necessarily high‑citation without broader adoption or clinical translation.

Limitations, blindspots & what would change the conclusion

• Missing ORCID, full institutional affiliation, and DOIs for the five supplied papers — prevents definitive matching to OpenAlex/Scopus/Web of Science profiles.
• No per-paper citation counts, journal impact factors, experimental sample sizes, or methods quality assessments for the five papers — we cannot evaluate methodological rigor without reading full texts.
• If the five papers correspond to a distinct, early‑career researcher, the low citation totals are plausible; conversely, if they belong to the high‑impact OpenAlex profile, the local numbers are incomplete or misassigned.
• To overturn the current conservative conclusion (uncertain strength due to ambiguity), provide DOIs or ORCID for the exact author — that would enable readout of per-paper quality, reproducibility signals, and downstream adoption.

Practical next steps (actionable)

1. Provide ORCID or institutional affiliation and DOIs for the five listed papers to permit unambiguous author matching and per‑paper quality assessment (read methods, sample sizes, animal ethics, statistical reporting).
2. If you want a deep dive, run an AI Science Agent to fetch the papers' DOIs, full texts, extract methods & raw data (if available), then produce per‑paper methodological and reproducibility assessments — click the Run AI Scientist Analysis button below.
3. When evaluating scientific strength, prefer evidence-based signals beyond citation counts: sample sizes, preclinical-to-clinical translation, independent replication, and data/code availability.